Artificial Oocyte Activation with Ca Ionophore Improves Reproductive Outcomes in Patients with Fertilization Failure and Poor Embryo Development in Previous ICSI Cycles

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Aug 28

PMID 37635975

Authors

Jing Ling Ruan

Shan Shan Liang

Jia Ping Pan

Zhi Qin Chen

Xiao Ming Teng

Affiliations

Soon will be listed here.

Abstract

Research Question: Does artificial oocyte activation (AOA) by a calcium ionophore (ionomycin) improve the previous fertilization failure or poor embryo development of intracytoplasmic sperm injection (ICSI) account for male factor infertility or other infertility causes?

Design: This retrospective study involved 114 patients receiving ICSI-AOA in Shanghai First Maternity and Infant Hospital with previous ICSI fertilization failure or poor embryo development. The previous ICSI cycles of the same patients without AOA served as the control group. The fertilization rates, cleavage rates, transferable embryo rates and blastocyst formation rates of the two groups were compared. Additionally, the clinical pregnancy, implantation rate and live birth rates were also compared to assess the efficiency and safety of AOA. Furthermore, two subgroup analyses were performed in this study based on the cause of infertility and the reason for AOA. The fertilization rate, embryonic development potential and clinical outcome were compared among groups.

Results: Among 114 ICSI-AOA cycles, the fertilization rate, top-quality embryo rate, implantation rate, clinical pregnancy per patient and live birth rate per patient were improved significantly compared with previous ICSI cycles (p<0.05 to P< 0.001), and the miscarriage rate in the AOA group was significantly lower than that of the control group (p<0.001). In the AOA subgroups based on the cause of infertility, the fertilization rates of each subgroup were significantly improved compared with previous control cycles except for the mixed factor infertility subgroup (p<0.05 to p<0.001). In the AOA subgroups based on the reason for AOA, the fertilization rates of each subgroup were significantly increased compared with those in their previous ICSI cycle without AOA (p<0.001); however, there was no significant difference in the top-quality embryo rate. No significant improvement was found in the implantation rates and the clinical pregnancy rate in each subgroup except for the poor embryo development subgroup. In the 114 AOA cycles, 35 healthy infants (21 singletons and 7 twins) were delivered without major congenital birth defects or malformations.

Conclusion: This study showed that AOA with the calcium ionophore ionomycin can improve the reproductive outcomes of patients with previous fertilization failure and poor embryo development after ICSI.

Citing Articles

Assessing the impact of calcium ionophore on pregnancy outcomes in artificial oocyte activation cycles: a 10-year update of systematic review and meta-analysis.

Zhang J, Sui Y, Xiao M, Sun X, Fu J J Assist Reprod Genet. 2024; 42(1):165-183.

PMID: 39557784 PMC: 11806169. DOI: 10.1007/s10815-024-03319-y.

Molecular Mechanism of Oocyte Activation in Mammals: Past, Present, and Future Directions.

Sugita H, Takarabe S, Kageyama A, Kawata Y, Ito J Biomolecules. 2024; 14(3).

PMID: 38540777 PMC: 10968515. DOI: 10.3390/biom14030359.

References

Sun B, Yeh J . Calcium Oscillatory Patterns and Oocyte Activation During Fertilization: a Possible Mechanism for Total Fertilization Failure (TFF) in Human In Vitro Fertilization?. Reprod Sci. 2020; 28(3):639-648. DOI: 10.1007/s43032-020-00293-5. View

Zhao S, Cui Y, Guo S, Liu B, Bian Y, Zhao S . Novel variants in ACTL7A and PLCZ1 are associated with male infertility and total fertilization failure. Clin Genet. 2023; 103(5):603-608. DOI: 10.1111/cge.14293. View

Nasr-Esfahani M, Razavi S, Javdan Z, Tavalaee M . Artificial oocyte activation in severe teratozoospermia undergoing intracytoplasmic sperm injection. Fertil Steril. 2008; 90(6):2231-7. DOI: 10.1016/j.fertnstert.2007.10.047. View

Yu Y, Nomikos M, Theodoridou M, Nounesis G, Lai F, Swann K . PLCζ causes Ca(2+) oscillations in mouse eggs by targeting intracellular and not plasma membrane PI(4,5)P(2). Mol Biol Cell. 2011; 23(2):371-80. PMC: 3258180. DOI: 10.1091/mbc.E11-08-0687. View

Yan Z, Fan Y, Wang F, Yan Z, Li M, OuYang J . Novel mutations in PLCZ1 cause male infertility due to fertilization failure or poor fertilization. Hum Reprod. 2020; 35(2):472-481. DOI: 10.1093/humrep/dez282. View

Jones K, Lane S . Molecular causes of aneuploidy in mammalian eggs. Development. 2013; 140(18):3719-30. DOI: 10.1242/dev.090589. View

Vanden Meerschaut F, Nikiforaki D, Heindryckx B, De Sutter P . Assisted oocyte activation following ICSI fertilization failure. Reprod Biomed Online. 2014; 28(5):560-71. DOI: 10.1016/j.rbmo.2014.01.008. View

Chen Z, Wang Y, Ng E, Zhao M, Pan J, Wu H . A randomized triple blind controlled trial comparing the live birth rate of IVF following brief incubation versus standard incubation of gametes. Hum Reprod. 2018; 34(1):100-108. DOI: 10.1093/humrep/dey333. View

Vanden Meerschaut F, Nikiforaki D, De Gheselle S, Dullaerts V, Van den Abbeel E, Gerris J . Assisted oocyte activation is not beneficial for all patients with a suspected oocyte-related activation deficiency. Hum Reprod. 2012; 27(7):1977-84. DOI: 10.1093/humrep/des097. View

10.

Kong P, Liu Y, Zhu Q, Yin M, Teng X . Effect of male age on pregnancy and neonatal outcomes in the first frozen-thawed embryo transfer cycles of IVF/ICSI treatment. Andrology. 2021; 9(5):1540-1548. DOI: 10.1111/andr.13031. View

11.

Lv M, Zhang D, He X, Chen B, Li Q, Ding D . Artificial oocyte activation to improve reproductive outcomes in couples with various causes of infertility: a retrospective cohort study. Reprod Biomed Online. 2020; 40(4):501-509. DOI: 10.1016/j.rbmo.2020.01.001. View

12.

Yang Y, Follo M, Cocco L, Suh P . The physiological roles of primary phospholipase C. Adv Biol Regul. 2013; 53(3):232-41. DOI: 10.1016/j.jbior.2013.08.003. View

13.

Shebl O, Trautner P, Enengl S, Reiter E, Allerstorfer C, Rechberger T . Ionophore application for artificial oocyte activation and its potential effect on morphokinetics: a sibling oocyte study. J Assist Reprod Genet. 2021; 38(12):3125-3133. PMC: 8666403. DOI: 10.1007/s10815-021-02338-3. View

14.

Tavalaee M, Nomikos M, Lai F, Nasr-Esfahani M . Expression of sperm PLCζ and clinical outcomes of ICSI-AOA in men affected by globozoospermia due to DPY19L2 deletion. Reprod Biomed Online. 2018; 36(3):348-355. DOI: 10.1016/j.rbmo.2017.12.013. View

15.

Yin M, Yu W, Li W, Zhu Q, Long H, Kong P . DNA methylation and gene expression changes in mouse pre- and post-implantation embryos generated by intracytoplasmic sperm injection with artificial oocyte activation. Reprod Biol Endocrinol. 2021; 19(1):163. PMC: 8567642. DOI: 10.1186/s12958-021-00845-7. View

16.

Meng X, Melo P, Jones C, Ross C, Mounce G, Turner K . Use of phospholipase C zeta analysis to identify candidates for artificial oocyte activation: a case series of clinical pregnancies and a proposed algorithm for patient management. Fertil Steril. 2020; 114(1):163-174. DOI: 10.1016/j.fertnstert.2020.02.113. View

17.

Yin M, Li M, Li W, Wu L, Yan Z, Zhao J . Efficacy of artificial oocyte activation in patients with embryo developmental problems: a sibling oocyte control study. Arch Gynecol Obstet. 2021; 305(5):1225-1231. DOI: 10.1007/s00404-021-06329-8. View

18.

Long R, Wang M, Yang Q, Hu S, Zhu L, Jin L . Risk of birth defects in children conceived by artificial oocyte activation and intracytoplasmic sperm injection: a meta-analysis. Reprod Biol Endocrinol. 2020; 18(1):123. PMC: 7731535. DOI: 10.1186/s12958-020-00680-2. View

19.

Shebl O, Reiter E, Enengl S, Allerstorfer C, Schappacher-Tilp G, Trautner P . Double ionophore application in cases with previous failed/low fertilization or poor embryo development. Reprod Biomed Online. 2022; 44(5):829-837. DOI: 10.1016/j.rbmo.2021.11.008. View

20.

Ebner T, Koster M, Shebl O, Moser M, van der Ven H, Tews G . Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril. 2012; 98(6):1432-7. DOI: 10.1016/j.fertnstert.2012.07.1134. View